Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine

Prostate adenocarcinoma (PRAD) is a leading cause of death among men. Messenger ribonucleic acid (mRNA) vaccine presents an attractive approach to achieve satisfactory outcomes; however, tumor antigen screening and vaccination candidates show a bottleneck in this field. We aimed to investigate the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiaonan, Xu, Hang, Yi, Xianyanling, Zhang, Tianyi, Wei, Qiang, Li, Hong, Ai, Jianzhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645679/
https://www.ncbi.nlm.nih.gov/pubmed/34872584
http://dx.doi.org/10.1186/s12943-021-01452-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645679/
https://www.ncbi.nlm.nih.gov/pubmed/34872584
http://dx.doi.org/10.1186/s12943-021-01452-1

Ejemplares similares